Cargando…

Response to ‘Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer’

Detalles Bibliográficos
Autores principales: Slevin, Finbar, Rodda, Sree Lakshmi, Bownes, Peter, Murray, Louise, Bottomley, David, Melody, Clare, Adiotomre, Ese, Al-Qaisieh, Bashar, Dugdale, Emma, Hulson, Oliver, Mason, Joshua, Smith, Jonathan, Henry, Ann M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327822/
https://www.ncbi.nlm.nih.gov/pubmed/32637660
http://dx.doi.org/10.1016/j.ctro.2020.06.001
_version_ 1783552623620653056
author Slevin, Finbar
Rodda, Sree Lakshmi
Bownes, Peter
Murray, Louise
Bottomley, David
Melody, Clare
Adiotomre, Ese
Al-Qaisieh, Bashar
Dugdale, Emma
Hulson, Oliver
Mason, Joshua
Smith, Jonathan
Henry, Ann M.
author_facet Slevin, Finbar
Rodda, Sree Lakshmi
Bownes, Peter
Murray, Louise
Bottomley, David
Melody, Clare
Adiotomre, Ese
Al-Qaisieh, Bashar
Dugdale, Emma
Hulson, Oliver
Mason, Joshua
Smith, Jonathan
Henry, Ann M.
author_sort Slevin, Finbar
collection PubMed
description
format Online
Article
Text
id pubmed-7327822
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-73278222020-07-06 Response to ‘Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer’ Slevin, Finbar Rodda, Sree Lakshmi Bownes, Peter Murray, Louise Bottomley, David Melody, Clare Adiotomre, Ese Al-Qaisieh, Bashar Dugdale, Emma Hulson, Oliver Mason, Joshua Smith, Jonathan Henry, Ann M. Clin Transl Radiat Oncol Article Elsevier 2020-06-10 /pmc/articles/PMC7327822/ /pubmed/32637660 http://dx.doi.org/10.1016/j.ctro.2020.06.001 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Slevin, Finbar
Rodda, Sree Lakshmi
Bownes, Peter
Murray, Louise
Bottomley, David
Melody, Clare
Adiotomre, Ese
Al-Qaisieh, Bashar
Dugdale, Emma
Hulson, Oliver
Mason, Joshua
Smith, Jonathan
Henry, Ann M.
Response to ‘Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer’
title Response to ‘Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer’
title_full Response to ‘Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer’
title_fullStr Response to ‘Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer’
title_full_unstemmed Response to ‘Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer’
title_short Response to ‘Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer’
title_sort response to ‘unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer’
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327822/
https://www.ncbi.nlm.nih.gov/pubmed/32637660
http://dx.doi.org/10.1016/j.ctro.2020.06.001
work_keys_str_mv AT slevinfinbar responsetounexpectedlowerbiochemicalcontrolofhighdoseratebrachytherapyboostthanlowdoseratebrachytherapyboostforclinicallylocalizedprostatecancer
AT roddasreelakshmi responsetounexpectedlowerbiochemicalcontrolofhighdoseratebrachytherapyboostthanlowdoseratebrachytherapyboostforclinicallylocalizedprostatecancer
AT bownespeter responsetounexpectedlowerbiochemicalcontrolofhighdoseratebrachytherapyboostthanlowdoseratebrachytherapyboostforclinicallylocalizedprostatecancer
AT murraylouise responsetounexpectedlowerbiochemicalcontrolofhighdoseratebrachytherapyboostthanlowdoseratebrachytherapyboostforclinicallylocalizedprostatecancer
AT bottomleydavid responsetounexpectedlowerbiochemicalcontrolofhighdoseratebrachytherapyboostthanlowdoseratebrachytherapyboostforclinicallylocalizedprostatecancer
AT melodyclare responsetounexpectedlowerbiochemicalcontrolofhighdoseratebrachytherapyboostthanlowdoseratebrachytherapyboostforclinicallylocalizedprostatecancer
AT adiotomreese responsetounexpectedlowerbiochemicalcontrolofhighdoseratebrachytherapyboostthanlowdoseratebrachytherapyboostforclinicallylocalizedprostatecancer
AT alqaisiehbashar responsetounexpectedlowerbiochemicalcontrolofhighdoseratebrachytherapyboostthanlowdoseratebrachytherapyboostforclinicallylocalizedprostatecancer
AT dugdaleemma responsetounexpectedlowerbiochemicalcontrolofhighdoseratebrachytherapyboostthanlowdoseratebrachytherapyboostforclinicallylocalizedprostatecancer
AT hulsonoliver responsetounexpectedlowerbiochemicalcontrolofhighdoseratebrachytherapyboostthanlowdoseratebrachytherapyboostforclinicallylocalizedprostatecancer
AT masonjoshua responsetounexpectedlowerbiochemicalcontrolofhighdoseratebrachytherapyboostthanlowdoseratebrachytherapyboostforclinicallylocalizedprostatecancer
AT smithjonathan responsetounexpectedlowerbiochemicalcontrolofhighdoseratebrachytherapyboostthanlowdoseratebrachytherapyboostforclinicallylocalizedprostatecancer
AT henryannm responsetounexpectedlowerbiochemicalcontrolofhighdoseratebrachytherapyboostthanlowdoseratebrachytherapyboostforclinicallylocalizedprostatecancer